Stroke Diagnostics and Therapeutics - Global Market Outlook (2017-2026)

   |      |      |  

Stroke Diagnostics and Therapeutics - Global Market Outlook (2017-2026)

Global Stroke Diagnostics and Therapeutics market is accounted for $23,849.39 Million in 2017 and is expected to reach $49,698.68 Million by 2026 growing at a CAGR of 8.5% during the forecast period. Factors such as technological advancement, growing aging population, and people suffering from diabetes are favouring the market. On the other hand, increasing health expenditure, hypertension and also increasing tobacco users are also fuelling the market. However factors such as unfavourable reimbursement scenario and high cost of treatments are hampering the market growth. Stroke is referred to brain attack occurs when there is a holdup in the supply of blood to the brain which leads brain cells to die.

Depending upon Application, Haemorrhagic Stroke is caused on account of the arteries in the brain either leaking blood or bursting open. When it happens, blood collects in the brain tissue. This is toxic for the brain tissue causing the cells in that area to weaken and die. It is one among the cause of death and a leading cause of serious, long-term disability across the world.

By Geography, stroke diagnostics and therapeutics market in Asia is expected to witness the high growth rate in and expected to remain top among other regions in the forecast period due to growing aging population, evolving R&D activities for drug discovery and development, increasing government support in the form of funding and developing healthcare infrastructure in the region. In addition, growing demographics and economies in the developing countries such as India, China, and Japan are expected to lead the growth in the stroke diagnostics and therapeutics market in Asia.

Some of the key players diagnostics and therapeutics market include are Abbott Laboratories, Cordis Corporation, Boston Scientific Corporation, Siemens AG, Genentech, Inc., Koninklijke Philips N.V., Medtronic plc, GE Healthcare, Stryker Corporation and Merck & Co., Inc.

Types Covered:
• Diagnostics
• Therapeutics               

Applications Covered:
• Haemorrhagic Stroke             
• Ischemic Stroke    

Regions Covered:

North America

US
Canada
Mexico

Europe

Germany
UK
Italy
France
Spain
Rest of Europe

Asia Pacific

Japan       
China       
India       
Australia 
New Zealand     
South Korea      
Rest of Asia Pacific   

South America

Argentina
Brazil
Chile
Rest of South America

Middle East & Africa

Saudi Arabia
UAE
Qatar
South Africa
Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 9 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

1 Executive Summary      
        
2 Preface       
 2.1 Abstract      
 2.2 Stake Holders     
 2.3 Research Scope     
 2.4 Research Methodology    
  2.4.1 Data Mining    
  2.4.2 Data Analysis    
  2.4.3 Data Validation    
  2.4.4 Research Approach    
 2.5 Research Sources     
  2.5.1 Primary Research Sources   
  2.5.2 Secondary Research Sources   
  2.5.3 Assumptions    
        
3 Market Trend Analysis     
 3.1 Introduction     
 3.2 Drivers      
 3.3 Restraints     
 3.4 Opportunities     
 3.5 Threats      
 3.6 Application Analysis    
 3.7 Emerging Markets     
 3.8 Futuristic Market Scenario    
        
4 Porters Five Force Analysis     
 4.1 Bargaining power of suppliers    
 4.2 Bargaining power of buyers    
 4.3 Threat of substitutes    
 4.4 Threat of new entrants    
 4.5 Competitive rivalry     
        
5 Global Stroke Diagnostics and Therapeutics Market, By Type           
 5.1 Introduction                    
 5.2 Diagnostics     
  5.2.1 Magnetic Resonance Imaging (MRI)  
  5.2.2 Computed Tomography Scan (CT scan)  
  5.2.3 Electrocardiography    
  5.2.4 Carotid Ultrasound    
  5.2.5 Cerebral Angiography       
  5.2.6 Other Diagnostics    
 5.3 Therapeutics                    
  5.3.1 Tissue Plasminogen Activator              
  5.3.2 Antiplatelet                    
  5.3.3 Antihypertensive                  
  5.3.4 Anticoagulant                 
        
6 Global Stroke Diagnostics and Therapeutics Market, By Application       
 6.1 Introduction                    
 6.2 Haemorrhagic Stroke                   
 6.3 Ischemic Stroke           
        
7 Global Stroke Diagnostics and Therapeutics Market, By Geography 
 7.1 Introduction     
 7.2 North America     
  7.2.1 US     
  7.2.2 Canada     
  7.2.3 Mexico     
 7.3 Europe      
  7.3.1 Germany     
  7.3.2 UK     
  7.3.3 Italy     
  7.3.4 France     
  7.3.5 Spain     
  7.3.6 Rest of Europe    
 7.4 Asia Pacific     
  7.4.1 Japan     
  7.4.2 China     
  7.4.3 India     
  7.4.4 Australia     
  7.4.5 New Zealand    
  7.4.6 South Korea    
  7.4.7 Rest of Asia Pacific    
 7.5 South America     
  7.5.1 Argentina    
  7.5.2 Brazil     
  7.5.3 Chile     
  7.5.4 Rest of South America   
 7.6 Middle East & Africa    
  7.6.1 Saudi Arabia    
  7.6.2 UAE      
  7.6.3 Qatar     
  7.6.4 South Africa    
  7.6.5 Rest of Middle East & Africa   
        
8 Key Developments      
 8.1 Acquisitions & Mergers    
 8.2 Agreements, Partnerships, Collaborations and Joint Ventures 
 8.3 Product Launch & Expansions     
 8.4 Other Activities     
        
9 Company Profiling      
 9.1 Abbott Laboratories     
 9.2 Cordis Corporation     
 9.3 Boston Scientific Corporation    
 9.4 Siemens AG     
 9.5 Genentech, Inc.     
 9.6 Koninklijke Philips N.V.     
 9.7 Medtronic plc     
 9.8 GE Healthcare     
 9.9 Stryker Corporation     
 9.10 Merck & Co., Inc       

 

Stroke Diagnostics and Therapeutics - Global Market Outlook (2017-2026)

List of Tables       
1 Global Stroke Diagnostics and Therapeutics Market Outlook, By Region (2016-2026) ($MN)
2 Global Stroke Diagnostics and Therapeutics Market Outlook, By Type (2016-2026) ($MN) 
3 Global Stroke Diagnostics and Therapeutics Market Outlook, By Diagnostics (2016-2026) ($MN) 
4 Global Stroke Diagnostics and Therapeutics Market Outlook, By Magnetic Resonance Imaging (MRI) (2016-2026) ($MN)
5 Global Stroke Diagnostics and Therapeutics Market Outlook, By Computed Tomography Scan (CT scan)  (2016-2026) ($MN)
6 Global Stroke Diagnostics and Therapeutics Market Outlook, By Electrocardiography  (2016-2026) ($MN)
7 Global Stroke Diagnostics and Therapeutics Market Outlook, By Carotid Ultrasound  (2016-2026) ($MN)
8 Global Stroke Diagnostics and Therapeutics Market Outlook, By Cerebral Angiography  (2016-2026) ($MN)
9 Global Stroke Diagnostics and Therapeutics Market Outlook, By Others  (2016-2026) ($MN) 
10 Global Stroke Diagnostics and Therapeutics Market Outlook, By Therapeutics  (2016-2026) ($MN) 
11 Global Stroke Diagnostics and Therapeutics Market Outlook, By Tissue Plasminogen Activator (2016-2026) ($MN)
12 Global Stroke Diagnostics and Therapeutics Market Outlook, By Antiplatelet  (2016-2026) ($MN) 
13 Global Stroke Diagnostics and Therapeutics Market Outlook, By Antihypertensive   (2016-2026) ($MN)
14 Global Stroke Diagnostics and Therapeutics Market Outlook, By Anticoagulant  (2016-2026) ($MN)
15 Global Stroke Diagnostics and Therapeutics Market Outlook, By Application (2016-2026) ($MN) 
16 Global Stroke Diagnostics and Therapeutics Market Outlook, By Haemorrhagic Stroke(2014-2022) ($MN)
17 Global Stroke Diagnostics and Therapeutics Market Outlook, By Ischemic Stroke  (2016-2026) ($MN)
18 North America  Stroke Diagnostics and Therapeutics Market Outlook, By Type (2016-2026) ($MN) 
19 North America  Stroke Diagnostics and Therapeutics Market Outlook, By Diagnostics (2016-2026) ($MN)
20 North America  Stroke Diagnostics and Therapeutics Market Outlook, By Magnetic Resonance Imaging (MRI) (2016-2026) ($MN)
21 North America  Stroke Diagnostics and Therapeutics Market Outlook, By Computed Tomography Scan (CT scan)  (2016-2026) ($MN)
22 North America  Stroke Diagnostics and Therapeutics Market Outlook, By Electrocardiography  (2016-2026) ($MN)
23 North America  Stroke Diagnostics and Therapeutics Market Outlook, By Carotid Ultrasound  (2016-2026) ($MN)
24 North America  Stroke Diagnostics and Therapeutics Market Outlook, By Cerebral Angiography (2016-2026) ($MN)
25 North America  Stroke Diagnostics and Therapeutics Market Outlook, By Others  (2016-2026) ($MN)
26 North America  Stroke Diagnostics and Therapeutics Market Outlook, By Therapeutics  (2016-2026) ($MN)
27 North America  Stroke Diagnostics and Therapeutics Market Outlook, By Tissue Plasminogen Activator (2016-2026) ($MN)
28 North America  Stroke Diagnostics and Therapeutics Market Outlook, By Antiplatelet  (2016-2026) ($MN)
29 North America  Stroke Diagnostics and Therapeutics Market Outlook, By Antihypertensive   (2016-2026) ($MN)
30 North America  Stroke Diagnostics and Therapeutics Market Outlook, By Anticoagulant  (2016-2026) ($MN)
31 North America  Stroke Diagnostics and Therapeutics Market Outlook, By Application (2016-2026) ($MN)
32 North America  Stroke Diagnostics and Therapeutics Market Outlook, By Haemorrhagic Stroke(2014-2022) ($MN)
33 North America  Stroke Diagnostics and Therapeutics Market Outlook, By Ischemic Stroke  (2016-2026) ($MN)
34 Europe  Stroke Diagnostics and Therapeutics Market Outlook, By Type (2016-2026) ($MN) 
35 Europe  Stroke Diagnostics and Therapeutics Market Outlook, By Diagnostics (2016-2026) ($MN) 
36 Europe  Stroke Diagnostics and Therapeutics Market Outlook, By Magnetic Resonance Imaging (MRI) (2016-2026) ($MN)
37 Europe  Stroke Diagnostics and Therapeutics Market Outlook, By Computed Tomography Scan (CT scan)  (2016-2026) ($MN)
38 Europe  Stroke Diagnostics and Therapeutics Market Outlook, By Electrocardiography (2016-2026) ($MN)
39 Europe  Stroke Diagnostics and Therapeutics Market Outlook, By Carotid Ultrasound (2016-2026) ($MN)
40 Europe  Stroke Diagnostics and Therapeutics Market Outlook, By Cerebral Angiography (2016-2026) ($MN)
41 Europe  Stroke Diagnostics and Therapeutics Market Outlook, By Others  (2016-2026) ($MN) 
42 Europe  Stroke Diagnostics and Therapeutics Market Outlook, By Therapeutics  (2016-2026) ($MN)
43 Europe  Stroke Diagnostics and Therapeutics Market Outlook, By Tissue Plasminogen Activator (2016-2026) ($MN)
44 Europe  Stroke Diagnostics and Therapeutics Market Outlook, By Antiplatelet  (2016-2026) ($MN)
45 Europe  Stroke Diagnostics and Therapeutics Market Outlook, By Antihypertensive   (2016-2026) ($MN)
46 Europe  Stroke Diagnostics and Therapeutics Market Outlook, By Anticoagulant  (2016-2026) ($MN)
47 Europe  Stroke Diagnostics and Therapeutics Market Outlook, By Application (2016-2026) ($MN) 
48 Europe  Stroke Diagnostics and Therapeutics Market Outlook, By Haemorrhagic Stroke(2014-2022) ($MN)
49 Europe  Stroke Diagnostics and Therapeutics Market Outlook, By Ischemic Stroke  (2016-2026) ($MN)
50 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Type (2016-2026) ($MN) 
51 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Diagnostics (2016-2026) ($MN)
52 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Magnetic Resonance Imaging (MRI) (2016-2026) ($MN)
53 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Computed Tomography Scan (CT scan)  (2016-2026) ($MN)
54 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Electrocardiography  (2016-2026) ($MN)
55 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Carotid Ultrasound  (2016-2026) ($MN)
56 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Cerebral Angiography (2016-2026) ($MN)
57 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Others  (2016-2026) ($MN) 
58 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Therapeutics  (2016-2026) ($MN)
59 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Tissue Plasminogen Activator (2016-2026) ($MN)
60 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Antiplatelet  (2016-2026) ($MN)
61 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Antihypertensive   (2016-2026) ($MN)
62 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Anticoagulant  (2016-2026) ($MN)
63 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Application (2016-2026) ($MN)
64 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Haemorrhagic Stroke(2014-2022) ($MN)
65 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Ischemic Stroke  (2016-2026) ($MN)
66 South America Stroke Diagnostics and Therapeutics Market Outlook, By Type (2016-2026) ($MN)
67 South America Stroke Diagnostics and Therapeutics Market Outlook, By Diagnostics (2016-2026) ($MN)
68 South America Stroke Diagnostics and Therapeutics Market Outlook, By Magnetic Resonance Imaging (MRI) (2016-2026) ($MN)
69 South America Stroke Diagnostics and Therapeutics Market Outlook, By Computed Tomography Scan (CT scan)  (2016-2026) ($MN)
70 South America Stroke Diagnostics and Therapeutics Market Outlook, By Electrocardiography  (2016-2026) ($MN)
71 South America Stroke Diagnostics and Therapeutics Market Outlook, By Carotid Ultrasound  (2016-2026) ($MN)
72 South America Stroke Diagnostics and Therapeutics Market Outlook, By Cerebral Angiography (2016-2026) ($MN)
73 South America Stroke Diagnostics and Therapeutics Market Outlook, By Others  (2016-2026) ($MN)
74 South America Stroke Diagnostics and Therapeutics Market Outlook, By Therapeutics  (2016-2026) ($MN)
75 South America Stroke Diagnostics and Therapeutics Market Outlook, By Tissue Plasminogen Activator (2016-2026) ($MN)
76 South America Stroke Diagnostics and Therapeutics Market Outlook, By Antiplatelet  (2016-2026) ($MN)
77 South America Stroke Diagnostics and Therapeutics Market Outlook, By Antihypertensive   (2016-2026) ($MN)
78 South America Stroke Diagnostics and Therapeutics Market Outlook, By Anticoagulant  (2016-2026) ($MN)
79 South America Stroke Diagnostics and Therapeutics Market Outlook, By Application (2016-2026) ($MN)
80 South America Stroke Diagnostics and Therapeutics Market Outlook, By Haemorrhagic Stroke(2014-2022) ($MN)
81 South America Stroke Diagnostics and Therapeutics Market Outlook, By Ischemic Stroke  (2016-2026) ($MN)
82 Middle East & Africa Stroke Diagnostics and Therapeutics Market Outlook, By Type (2016-2026) ($MN)
83 Middle East & Africa Stroke Diagnostics and Therapeutics Market Outlook, By Diagnostics (2016-2026) ($MN)
84 Middle East & Africa Stroke Diagnostics and Therapeutics Market Outlook, By Magnetic Resonance Imaging (MRI) (2016-2026) ($MN)
85 Middle East & Africa Stroke Diagnostics and Therapeutics Market Outlook, By Computed Tomography Scan (CT scan)  (2016-2026) ($MN)
86 Middle East & Africa Stroke Diagnostics and Therapeutics Market Outlook, By Electrocardiography  (2016-2026) ($MN)
87 Middle East & Africa Stroke Diagnostics and Therapeutics Market Outlook, By Carotid Ultrasound  (2016-2026) ($MN)
88 Middle East & Africa Stroke Diagnostics and Therapeutics Market Outlook, By Cerebral Angiography (2016-2026) ($MN)
89 Middle East & Africa Stroke Diagnostics and Therapeutics Market Outlook, By Others  (2016-2026) ($MN)
90 Middle East & Africa Stroke Diagnostics and Therapeutics Market Outlook, By Therapeutics  (2016-2026) ($MN)
91 Middle East & Africa Stroke Diagnostics and Therapeutics Market Outlook, By Tissue Plasminogen Activator (2016-2026) ($MN)
92 Middle East & Africa Stroke Diagnostics and Therapeutics Market Outlook, By Antiplatelet  (2016-2026) ($MN)
93 Middle East & Africa Stroke Diagnostics and Therapeutics Market Outlook, By Antihypertensive   (2016-2026) ($MN)
94 Middle East & Africa Stroke Diagnostics and Therapeutics Market Outlook, By Anticoagulant  (2016-2026) ($MN)
95 Middle East & Africa Stroke Diagnostics and Therapeutics Market Outlook, By Application (2016-2026) ($MN)
96 Middle East & Africa Stroke Diagnostics and Therapeutics Market Outlook, By Haemorrhagic Stroke(2014-2022) ($MN)
97 Middle East & Africa Stroke Diagnostics and Therapeutics Market Outlook, By Ischemic Stroke  (2016-2026) ($MN)

.